Effects of cysteine on the pharmacokinetics of intravenous clarithromycin in rats with protein-calorie malnutrition

Life Sciences

Volumn 73, Issue 14, 2003, Pages 1783-1794

  Ahn, Choong Y ^a   Kim, Eun J ^a   Kwon, Jong W ^b   Chung, Suk J ^a   Kim, Sang G ^a   Shim, Chang K ^a   Lee, Myung G ^a  

^a Seoul National University   (South Korea)

^b Dong A Pharmaceutical Company   (South Korea)

Author keywords

Clarithromycin; Cysteine; Cytochrome P450 3A23; Pharmacokinetics; Protein calorie malnutrition; Rat

Indexed keywords

14 HYDROXYCLARITHROMYCIN; CASEIN; CLARITHROMYCIN; CYSTEINE; CYTOCHROME P450; CYTOCHROME P450 3A23; CYTOCHROME P450 3A4; DRUG METABOLITE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DIET; DIET SUPPLEMENTATION; DRUG EFFECT; INCUBATION TIME; KIDNEY CLEARANCE; LIVER HOMOGENATE; LIVER MICROSOME; MALE; NONHUMAN; PROTEIN CALORIE MALNUTRITION; RAT;

EID: 0042347448     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(03)00540-X     Document Type: Article

References (31)

1. Denke M., Wilson J.D. Protein and energy malnutrition. Fauci A.S., Braunwald E., Isselbacher K.J., Wilson J.D., Martin J.B., Kasper D.L., Hauser S.L., Longo D.L. Principles of Internal Medicine. 14th ed. 1998;452-454 McGraw-Hill, New York.
2. Bistrian B.R., Blackburn G.L., Hallowell E., Heddle R. Protein status of general surgical patients. The Journal of the American Medical Association. 230(6):1974;858-860.
3. Bistrian B.R., Blackburn G.L., Vitale J., Cochran D., Naylor J. Prevalence of malnutrition in general medical patients. The Journal of the American Medical Association. 235(15):1976;1567-1570.
4. Woodward B., Filteau S.M. Immunoenhancement in wasting protein-energy malnutrition: Assessment of present information and proposal of a new concept. Advanced Nutrition Research. 8:1990;11-34.
5. Wykes L.J., Fiorotto M., Burrin D.G., Rosario M.D., Frazer M.E., Pond W.G., Jahoor F. Chronic low protein intakes reduce tissue protein synthesis in a pig model of protein malnutrition. The Journal of Nutrition. 126(5):1996;1481-1488.
6. Buchanan N. Drug kinetics in protein energy malnutrition. South African Medical Journal. 53(9):1978;327-330.
7. Krishnaswamy K. Drug metabolism and pharmacokinetics in malnutrition. Clinical Pharmacokinetics. 3(3):1978;216-240.
8. Cho M.K., Kim Y.G., Lee M.G., Kim S.G. Suppression of rat hepatic cytochrome P450s by protein-calorie malnutrition: Complete or partial restoration by cysteine or methionine supplementation. Archives of Biochemistry and Biophysics. 372(1):1999;150-158.
9. Kim Y.G., Cho M.K., Kwon J.W., Kim S.G., Kim S.H., Lee M.G. Effects of cysteine on the pharmacokinetics and pharmacodynamics of intravenous and oral azosemide in rats with protein-calorie malnutrition. Life Sciences. 68(21):2001;2329-2345.
10. Kim Y.G., Cho M.K., Kwon J.W., Kim S.G., Lee M.G. Effects of cysteine on the pharmacokinetics of intravenous adriamycin in rats with protein-calorie malnutrition. Research Communications in Molecular Pathology and Pharmacology. 107(5-6):2000;361-376.
11. Kim Y.G., Cho M.K., Kwon J.W., Kim S.G., Chung S.J., Shim C.-K., Lee M.G. Effects of cysteine on the pharmacokinetics of intravenous chlorzoxazone in rats with protein-calorie malnutrition. Biopharmaceutics & Drug Disposition. 23(3):2002;121-129.
12. Kim Y.G., Cho M.K., Kwon J.W., Kim S.G., Chung S.J., Shim C.-K., Lee M.G. Effects of cysteine on the pharmacokinetics of intravenous phenytoin in rats with protein-calorie malnutrition. International Journal of Pharmaceutics. 229(1-2):2001;45-55.
13. Rodvold K.A. Clinical pharmacokinetics of clarithromycin. Clinical Pharmacokinetics. 37(5):1999;385-398.
14. Fraschini F., Scaglione F., Demartini G. Clarithromycin clinical pharmacokinetics. Clinical Pharmacokinetics. 25(3):1993;189-204.
15. Lewis D.F.V. P450 substrate specificity and metabolism. Cytochromes P450 Structure, Function and Mechanism. 1996;123 Talyor & Francis, Bristol.
16. Benito López P., Gálvez Moreno M.A., Corpas Jiménez M.S., Calañas Continente A. Influence of nutritional status on the organism's response to infectious disease. Revista Clinica Espanola. 193(5):1993;255-260.
17. Kim S.H., Kim W.B., Lee M.G. Pharmacokinetic changes of a new carbapenem, DA-1131, after intravenous administration to spontaneously hypertensive rats and deoxycorticosterone acetate-salt-induced hypertensive rats. Drug Metabolism and Disposition. 27(6):1999;710-716.
18. Litterst C.L., Mimnaugh E.G., Regan R.L., Gram T.E. Comparison of in vitro drug metabolism by lung, liver, and kidney of several common laboratory species. Drug Metabolism and Disposition. 3(4):1975;259-265.
19. Chu S.Y., Sennello L.T., Sonders R.C. Simultaneous determination of clarithromycin and 14(R)-hydroxyclarithromycin in plasma and urine using high-performance liquid chromatography with electrochemical detection. Journal of Chromatography. 571(1-2):1991;199-208.
20. Lowry O.H., Rosebrough N.G., Farr A.L., Randall R.J. Protein measurement with Folin phenol reagent. The Journal of Biological Chemistry. 193:1951;265-275.
21. Lineweaver H., Burk D. The determination of enzyme dissociation constants. Journal of the American Chemical Society. 56:1934;658-666.
22. Chiou W.L. Critical evaluation of potential error in pharmacokinetic studies using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve. Journal of Pharmacokinics and Biopharmaceutics. 6(6):1978;539-546.
23. Gibaldi M., Perrier D. Pharmacokinetics. 2nd ed. 1982;Dekker, New York.
24. Kim S.H., Choi Y.M., Lee M.G. Pharmacokinetics and pharmacodynamics of furosemide in protein-calorie malnutrition. Journal of Pharmacokinetics and Biopharmaceutics. 21(1):1993;1-17.
25. Chiou W.L. New calculation method of mean total body clearance of drugs and its application to dosage regimens. Journal of Pharmaceutical Sciences. 69(1):1980;90-91.
26. Chiou W.L. New calculation method of mean apparent drug volume of distribution and application to rational dosage regimen. Journal of Pharmaceutical Sciences. 68(8):1979;1067-1069.
27. Eatman F.B., Colburn W.A., Boxenbaum H.G., Posmanter H.N., Weinfeld R.E., Ronfeld R., Weissman L., Moore J.D., Gibaldi M., Kaplan S.A. Pharmacokinetics of diazepam following multiple dose oral administration to healthy human subjects. Journal of Pharmacokinetics and Biopharmaceutics. 5(5):1977;481-494.
28. Kohno Y., Yoshida H., Suwa T., Suga T. Comparative pharmacokinetics of clarithromycin (TE-031), a new macrolide antibiotic, and erythromycin in rats. Antimicrobial Agents and Chemotherapy. 33(5):1989;751-756.
29. Ohtani H., Taninaka C., Hanada E., Kotaki H., Sato H., Sawada Y., Iga T. Comparative pharmacodynamic analysis of Q-T interval prolongation induced by the macrolides clarithromycin, roxithromycin, and azithromycin in rats. Antimicrobial Agents and Chemotherapy. 44(10):2000;2630-2637.
30. Davies B., Morris T. Physiological parameters in laboratory animals and humans. Pharmaceutical Research. 10(7):1993;1093-1095.
31. Mitruka B.M., Rawnsley H.M. Clinical Biomedical and Hematological Reference Values in Normal Experimental Animals and Normal Humans. 2nd ed. 1981;67 Masson Publishing USA Inc. New York.